GYNICA
Gynica is a research and development company specializing in therapeutic cannabis research in the field of women's health. The company changing the culture of gynecological treatment through clinically-proven, cannabinoid-based solutions. Gynica's preclinical trial of a cannabinoid-based treatment for endometriosis is already showing promising results. Gynica develops medical treatments based on innovative technology and an advanced understanding of the pharmacological effects of cannabinoids that target specifically female symptoms and diseases. The company was founded in 2018 and is based in Jerusalem, Yerushalayim, Israel.
GYNICA
Industry:
Biotechnology Cannabis Health Care Medical
Founded:
2017-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.gynica.com
Total Employee:
1+
Status:
Active
Contact:
+972 (73) 733 0300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Bioscan Research
Bioscan Research develops a screening and monitoring medical device for early detection of diseases.
Red C Biotech
Red C Biotech is a pre-clinical, development stage company that aims to save lives by collaborating with organizations.
Current Employees Featured
Founder
Official Site Inspections
http://www.gynica.com Semrush global rank: 2.52 M Semrush visits lastest month: 6.97 K
- Host name: 218.28.185.35.bc.googleusercontent.com
- IP address: 35.185.28.218
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Gynica"
About - Gynica
Gynica is a biotech company driven to improve the lives of hundreds of millions of women worldwide suffering from Endometriosis, by providing safe, effective, non-hormonal, intra …See details»
Gynica - Crunchbase Company Profile & Funding
Gynica is a research and development company specializing in therapeutic cannabis research in the field of women's health. The company changing the culture of gynecological treatment through clinically-proven, cannabinoid …See details»
Team - Gynica
A Professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel-Aviv University, Prof. Hod serves as a Chief Consultant for Perinatal Medicine to Clalit Health Services, Israel’s …See details»
Gynica Healthcare - LinkedIn
Gynica is a femtech company leading in the clinical development of cannabinoid-based therapeutic solutions to treat gynecological conditions and improve women’s quality of life.See details»
Gynica Company Profile: Valuation, Funding & Investors - PitchBook
Gynica was founded in 2017. Who is the founder of Gynica? Yotam Hod and Dor Hershkovitz are the founders of Gynica. Who is the CEO of Gynica? Yotam Hod is the CEO of Gynica. Where …See details»
Gynica - Products, Competitors, Financials, Employees, …
Gynica is a femtech company that focuses on the clinical development of cannabinoid-based therapeutic solutions within the healthcare industry. Use the CB Insights Platform to explore …See details»
Gynica - Contacts, Employees, Board Members, Advisors & Alumni …
Gynica is a research and development company specializing in therapeutic cannabis research in the field of women's health. ... Products. Resources. Pricing. Resources. Log In. Organization. …See details»
Israel's Gynica starts clinical trial for endometriosis cure
Mar 14, 2024 Israeli biotech startup Gynica said on Thursday it had launched a clinical trial for a treatment for endometriosis, raising hopes for a cure for the disease which afflicts one in ten …See details»
Gilda D’Incerti joins Gynica Advisory Board against …
Gilda D’Incerti, CEO and founder of PQE Group, has joined the advisory board of Gynica.. Co-founded by Yotam Hod, Gynica is an Israeli biotech company that is changing the future of women’s health by developing safe, effective, controlled …See details»
Gynica announces First-in-Human Clinical Trial of Novel IntraVag ...
Mar 14, 2024 Gynica, a clinical-stage women's health biotech startup developing a novel Endometriosis treatment, announces today the submission of a first-in-human Phase 1 trial. …See details»
Gynica announces First-in-Human Clinical Trial of Novel IntraVag ...
Mar 14, 2024 Gynica, which was founded in 2019, set a goal to develop a solution for one of the most common but untreated diseases in the world - Endometriosis; a debilitating disease …See details»
Gynica
Gynica presented its scientific work at the University of Oxford . March 2022 . Read moreSee details»
Endometriosis latest target for medical cannabis research
Nov 7, 2018 Gynica, an Israeli startup specializing in cannabis-based solutions in the field of women’s health, is the first company that will carry out research and development at the newly …See details»
Israel's Gynica starts clinical trial for endometriosis cure
JERUSALEM, March 14 (Reuters) - Israeli biotech startup Gynica said on Thursday it had launched a clinical trial for a treatment for endometriosis, ... according to the World Health …See details»
Women's health biotech startup Gynica announces first-in-human …
Mar 18, 2024 Gynica, a clinical-stage women's health biotech startup developing a novel Endometriosis treatment, has announced the submission of a first-in-human Phase 1 trial.The …See details»
Femtech Firm Aims To Cure Endometriosis With Cannabinoids
Apr 7, 2024 The World Health Organization says that while it affects 1 in 10 women on the planet, treatments to alleviate the symptoms of endometriosis, such as medication or surgery, …See details»
Gynica Commences First-in-Human Clinical Trial for Novel …
Mar 14, 2024 Gynica, a clinical-stage biotech startup focused on women’s health, has announced the initiation of a first-in-human Phase 1 clinical trial for a novel Endometriosis …See details»
Gynica to launch trial of cannabinoid-based endometriosis therapies
Mar 20, 2024 The first patient on the trial will be dosed by the end of this year and the trial will enrol 24 patients with endometriosis, said Hod. The two pharmaceutical-standard cannabinoid …See details»
News - Gynica
Gynica is currently running a preclinical trial to identify the most effective cannabinoid formulation for endometriosis patients. Using Strainprint’s proprietary digital research platform with an …See details»